Search Results
Dr. Louis Weiner Discusses the T-DM1 EMILIA Trial for HER2-Positive Breast Cancer
Dr. Debu Tripathy Discusses the Updated EMILIA Trial Results for T-DM1
Phase 3 Trial Investigates T-DM1 and Pertuzumab in HER2+ Breast Cancer
How Breast Cancer Treatment Kadcyla (T-DM1) Works
Dr. Tripathy Discusses Impact of T-DM1 in HER2+ Breast Cancer
Upfront T-DM1 in HER2-Positive Breast Cancer
Dr. Esteva Discusses T-DM1 in HER2-Positive Breast Cancer
The New T-DM1 Breast Cancer Drug, An Oncologist's Reaction
Dr. Jhaveri Discusses the Utility of T-DM1 in the Neoadjuvant Setting
Dr. Perez Discusses T-DM1 and the MARIANNE Trial
Dr. Howard A. Burris on the Potential of T-DM1 in Breast Cancer
Dr. Julie Gralow Discusses T-DM1-Induced Thrombocytopenia
